AbbVie Inc. (BCBA:ABBV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of ARS 542.58 trillion. The enterprise value is 633.26 trillion.

Market Cap	542.58T
Enterprise Value	633.26T

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Jan 16, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	73.71%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 168.61 and the forward PE ratio is 15.74.

PE Ratio	168.61
Forward PE	15.74
PS Ratio	6.64
PB Ratio	-152.33
P/TBV Ratio	n/a
P/FCF Ratio	20.11
P/OCF Ratio	18.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.78, with an EV/FCF ratio of 23.47.

EV / Earnings	196.79
EV / Sales	7.40
EV / EBITDA	14.78
EV / EBIT	20.76
EV / FCF	23.47

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.51%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.51%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	1.49B
Profits Per Employee	58.51M
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-1,007.32B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +58.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+58.53%
50-Day Moving Average	34,198.40
200-Day Moving Average	28,578.20
Relative Strength Index (RSI)	41.41
Average Volume (20 Days)	1,353

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.32

Income Statement

In the last 12 months, AbbVie had revenue of ARS 81.74 trillion and earned 3.22 trillion in profits. Earnings per share was 1,809.89.

Revenue	81.74T
Gross Profit	58.41T
Operating Income	29.14T
Pretax Income	2.28T
Net Income	3.22T
EBITDA	40.46T
EBIT	29.14T
Earnings Per Share (EPS)	1,809.89

Balance Sheet

The company has 7.77 trillion in cash and 94.36 trillion in debt, with a net cash position of -86,585.45 billion.

Cash & Cash Equivalents	7.77T
Total Debt	94.36T
Net Cash	-86,585.45B
Net Cash Per Share	n/a
Equity (Book Value)	-3,561.93B
Book Value Per Share	-2,048.75
Working Capital	-14,872.67B

Cash Flow

In the last 12 months, operating cash flow was 28.59 trillion and capital expenditures -1,611.71 billion, giving a free cash flow of 26.98 trillion.

Operating Cash Flow	28.59T
Capital Expenditures	-1,611.71B
Free Cash Flow	26.98T
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 544.57, which amounts to a dividend yield of 1.68%.

Dividend Per Share	544.57
Dividend Yield	1.68%
Dividend Growth (YoY)	43.76%
Years of Dividend Growth	5
Payout Ratio	30.09%
Buyback Yield	-0.01%
Shareholder Yield	1.61%
Earnings Yield	0.59%
FCF Yield	4.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7